Aceto Pharmaceutical (ACET +2.1%) gets a boost today from what appears to be a delayed reaction...


Aceto Pharmaceutical (ACET +2.1%) gets a boost today from what appears to be a delayed reaction to yesterday's launch of its generic Clindamycin Palmitate Hydrochloride for Oral Solution, an FDA approved generic version of Pfizer's (PFE -0.6%) Cleocin Pediatric. U.S. market sales for Clindamycin Palmitate Hydrochloride - which is an antibiotic that is used to treat serious bacterial infections - were approximately $59M for the twelve months ended June 30.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs